Reviva Pharmaceuticals Holdings, Inc. (RVPH)

NASDAQ: RVPH · IEX Real-Time Price · USD

1.050

-0.030 (-2.78%)

At close: Jul 19, 2024, 4:00 PM

1.100

+0.050 (4.76%)

Pre-market: Jul 22, 2024, 7:40 AM EDT

RVPH Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	8.72	8.08	5.36	5.25	2.14	0.18
Research & Development	31.97	31.42	22.87	4.85	0.3	0.2
Operating Expenses	40.69	39.5	28.23	10.1	2.43	0.38
Operating Income	-40.69	-39.5	-28.23	-10.1	-2.43	-0.38
Interest Expense / Income	0	0	0	0	1.45	0.47
Other Expense / Income	-0.62	-0.26	0.01	-1.59	-0.11	-0
Pretax Income	-40.07	-39.24	-28.24	-8.52	-3.78	-0.85
Income Tax	0.02	0.02	0.02	0.01	0	0
Net Income	-40.09	-39.26	-28.26	-8.52	-3.78	-0.85
Shares Outstanding (Basic)	30	24	20	15	3	3
Shares Outstanding (Diluted)	30	24	20	15	3	3
Shares Change	36.89%	21.94%	31.95%	383.10%	10.60%	-
EPS (Basic)	-1.59	-1.65	-1.45	-0.58	-1.24	-0.31
EPS (Diluted)	-1.59	-1.65	-1.45	-0.58	-1.24	-0.31
Free Cash Flow	-32.1	-28.32	-18.96	-10.67	-4.07	-0.22
Free Cash Flow Per Share	-1.07	-1.19	-0.97	-0.72	-1.33	-0.08
EBITDA	-40.07	-39.24	-28.24	-8.52	-2.33	-0.38
Depreciation & Amortization	0	0	0	0	0	0
EBIT	-40.07	-39.24	-28.24	-8.52	-2.33	-0.38

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).